369
Views
1
CrossRef citations to date
0
Altmetric
Original Research

“Stories of starting”: Understanding the complex contexts of opioid misuse initiation

, MSc, , PhD, , BA, , PhD, , MD, MPH & , MD, MPH

References

  • Wilson N, Kariisa M, Seth P, Smith HI, Davis N. Drug and opioid-involved overdose deaths – United States, 2017–2018. MMWR Morb Mortal Wkly Rep. 2020;69 (11):290–297.
  • National Institute on Drug Abuse. Pennsylvania Opioid Summary. Revised May 2019; https://www.drugabuse.gov/opioid-summaries-by-state/pennsylvania-opioid-summary. Accessed Accessed August 12, 2019.
  • Leslie DL, Ba DM, Agbese E, Xing X, Liu G. The economic burden of the opioid epidemic on states: the case of Medicaid. Am J Manag Care. 2019;25(13 Suppl):S243–S249.
  • Zajac G, Nur SA, Kreager DA, Sterner G. Estimated costs to the Pennsylvania criminal justice system resulting from the opioid crisis. Am J Manag Care. 2019;25(13 Suppl):S250–S255.
  • Crowley DM, Connell CM, Jones D, Donovan MW. Considering the child welfare system burden from opioid misuse: research priorities for estimating public costs. Am J Manag Care. 2019;25(13 Suppl):S256–S263.
  • Morgan PL, Wang Y. The opioid epidemic, neonatal abstinence syndrome, and estimated costs for special education services. Am J Manag Care. 2019;25(13 Suppl):S264–S269.
  • Kawasaki S, Sharfstein JM. The cost of the opioid epidemic, in context. Am J Manag Care. 2019;25(13 Suppl):S241–S242.
  • Prevention CfDCa. Opioid Overdose, Opioid Basics, Commonly Used Terms. 2020.
  • Cicero TJ, Ellis MS. The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse. Dialogues Clin Neurosci. 2017;19(3):259–269.
  • Jones CM. Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers – United States, 2002–2004 and 2008–2010. Drug Alcohol Depend. 2013;132(1–2):95–100.
  • Lankenau SE, Teti M, Silva K, Jackson Bloom J, Harocopos A, Treese M. Initiation into prescription opioid misuse amongst young injection drug users. Int J Drug Policy. 2012;23(1):37–44.
  • Dube SR, Felitti VJ, Dong M, Chapman DP, Giles WH, Anda RF. Childhood abuse, neglect, and household dysfunction and the risk of illicit drug use: the adverse childhood experiences study. Pediatrics. 2003;111(3):564–572.
  • Simpson TL, Miller WR. Concomitance between childhood sexual and physical abuse and substance use problems. A review. Clin Psychol Rev. 2002;22(1):27–77.
  • Blanco C, Wall MM, Liu SM, Olfson M. Toward a comprehensive developmental model of prescription opioid use disorder. J Clin Psychiatry. 2019;81(1):19m12775.
  • Grant BF, Dawson DA. Age of onset of drug use and its association with DSM-IV drug abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. J Subst Abuse. 1998;10(2):163–173.
  • Trenz RC, Scherer M, Harrell P, Zur J, Sinha A, Latimer W. Early onset of drug and polysubstance use as predictors of injection drug use among adult drug users. Addict Behav. 2012;37(4):367–372.
  • Muhuri P, Gfroerer J, Davies M. Administration SAnMHS. Associations of Nonmedical Pain Reliever Use and Initiation of Heroin Use in the United States. Rockville: CBHSQ Data Review; 2013.
  • Cicero TJ, Ellis MS, Surratt HL, Kurtz SP. The changing face of heroin use in the United States: a retrospective analysis of the past 50 years. JAMA Psychiatry. 2014;71(7):821–826.
  • Cerda M, Santaella J, Marshall BD, Kim JH, Martins SS. Nonmedical prescription opioid use in childhood and early adolescence predicts transitions to heroin use in young adulthood: a national study. J Pediatr. 2015;167(3):605–612.
  • Cicero TJ, Ellis MS, Kasper ZA. Increased use of heroin as an initiating opioid of abuse. Addict Behav. 2017;74:63–66.
  • Cicero TJ, Kasper ZA, Ellis MS. Increased use of heroin as an initiating opioid of abuse: Further considerations and policy implications. Addict Behav. 2018;87:267–271.
  • Ciccarone D, Ondocsin J, Mars SG. Heroin uncertainties: exploring users’ perceptions of fentanyl-adulterated and -substituted ‘heroin’. Int J Drug Policy. 2017;46:146–155.
  • Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179.
  • Hacker K, Jones LD, Brink L, et al. Linking opioid-overdose data to human services and criminal justice data: opportunities for intervention. Public Health Rep. 2018;133(6):658–666.
  • Analytics AC. Opioid-related overdose deaths in Allegheny County: Report and Maps. 2018. https://www.alleghenycountyanalytics.us/index.php/2018/02/15/opioid-related-overdose-deaths-allegheny-county-report-data-visualizations/.
  • Allegheny County Department of Human Services. Heat map of opioid-related overdose deaths in Allegheny County, 2015–2016. 2018. https://www.alleghenycountyanalytics.us/wp-content/uploads/2018/02/ACDHS-Opioid-Overdose-Deaths-Heat-Map-020618.pdf. Accessed Accessed June 01, 2018.
  • Goodman RA, Bunnell R, Posner SF. What is “community health”? Examining the meaning of an evolving field in public health. Prev Med. 2014;67(Suppl 1):S58–S61.
  • MacQueen KM, McLellan E, Metzger DS, et al. What is community? An evidence-based definition for participatory public health. Am J Public Health. 2001;91(12):1929–1938.
  • Penrod J, Preston DB, Cain RE, Starks MT. A discussion of chain referral as a method of sampling hard-to-reach populations. J Transcult Nurs. 2003;14(2):100–107.
  • Mattingly C, Garro L. Narrative representations of illness and healing. Introduction. Soc Sci Med. 1994;38(6):771–774.
  • Kleinman A. The Illness Narratives: Suffering, Healing, and the Human Condition. New York, NY: Basic Books; 1988.
  • Mattingly C, Lawlor M. Learning from stories: narrative interviewing in cross-cultural research. Scand J Occup Ther. 2000;7(1):4–14.
  • Morgan DL. Qualitative content analysis: a guide to paths not taken. Qual Health Res. 1993;3(1):112–121.
  • Guest G, MacQueen K, Namey E. Applied Thematic Analysis. Thousand Oaks, CA: SAGE Publications, Inc; 2012.
  • Lincoln Y, Guba E. Naturalistic Inquiry. Newbury Park, CA: Sage; 1985.
  • Elo S, Kyngas H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–115.
  • Guest G, Bunce A, Johnson L. How many interviews are enough? An experiment with data saturation and variability. Field Methods. 2006;18(1):59–82.
  • Han B, Compton WM, Blanco C, Crane E, Lee J, Jones CM. Prescription opioid use, misuse, and use disorders in U.S. adults: 2015 National Survey on Drug Use and Health. Ann Intern Med. 2017;167(5):293–301.
  • Netherland J, Hansen H. White opioids: pharmaceutical race and the war on drugs that wasn’t. Biosocieties. 2017;12(2):217–238.
  • McLean K. From “junkies” to “soccer moms”: newspaper representations of overdose, 1988–2014. Crit Crim. 2017;25(3):411–432.
  • Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183–188.
  • King NB, Fraser V, Boikos C, Richardson R, Harper S. Determinants of increased opioid-related mortality in the United States and Canada, 1990–2013: a systematic review. Am J Public Health. 2014;104(8):e32–e42.
  • Harocopos A, Allen B, Paone D. Circumstances and contexts of heroin initiation following non-medical opioid analgesic use in New York City. Int J Drug Policy. 2016;28:106–112.
  • Rigg KK, McLean K, Monnat SM, Sterner GE, 3rd, Verdery AM. Opioid misuse initiation: implications for intervention. J Addict Dis. 2019;37(3–4):11–122.
  • Rigg KK, Murphy JW. Understanding the etiology of prescription opioid abuse: implications for prevention and treatment. Qual Health Res. 2013;23(7):963–975.
  • Turner S, Mota N, Bolton J, Sareen J. Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety. 2018;35(9):851–860.
  • Gowing L, Ali R, White JM. Buprenorphine for the management of opioid withdrawal. Cochrane Database Syst Rev. 2009;(3):CD002025.
  • Berna C, Kulich RJ, Rathmell JP. Tapering long-term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo Clin Proc. 2015;90(6):828–842.
  • Sullivan MD, Turner JA, DiLodovico C, D’Appollonio A, Stephens K, Chan YF. Prescription opioid taper support for outpatients with chronic pain: a randomized controlled trial. J Pain. 2017;18(3):308–318.
  • Volkow N. Drugs, brains, and behavior: the science of addiction. NIH Medicine Plus. 2012;2(2):14–17.
  • Volkow ND, Boyle M. Neuroscience of addiction: relevance to prevention and treatment. Am J Psychiatry. 2018;175(8):729–740.
  • Kleber HD, Weiss RD, Anton RF, et al. Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry. 2006;163(8 Suppl):5–82.
  • Scanlon DP, Hollenbeak CS. Preventing the next crisis: six critical questions about the opioid epidemic that need answers. Am J Manag Care. 2019;25(13 Suppl):S234–S238.
  • Compton WM, Jones CM, Baldwin GT, Harding FM, Blanco C, Wargo EM. Targeting youth to prevent later substance use disorder: an underutilized response to the US opioid crisis. Am J Public Health. 2019;109(S3):S185–S189.
  • Fassbender L, Zander GB, Levine RL. Beyond rescue, treatment, and prevention: understanding the broader impact of the opioid epidemic at the state level. Am J Manag Care. 2019;25(13 Suppl):S239–S240.
  • Fraser M, Plescia M. The opioid epidemic’s prevention problem. Am J Public Health. 2019;109(2):215–217.
  • CDC. Drug overdose deaths. 2018. cdc.gov/drugoverdose/data/statedeaths.html. Accessed November 21, 2019.
  • Ciccarone D. Fentanyl in the US heroin supply: a rapidly changing risk environment. Int J Drug Policy. 2017;46:107–111.
  • McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addiction. 2016;111(7):1177–1187.
  • Programs NRCaIoMPoNEaBD. Preventing HIV Transmission: The Role of Sterile Needles and Bleach. Washington, DC.: National Academies Press (US); 1995.
  • Compton WM, Thomas YF, Stinson FS, Grant BF. Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007;64(5):566–576.
  • Das JK, Salam RA, Arshad A, Finkelstein Y, Bhutta ZA. Interventions for adolescent substance abuse: an overview of systematic reviews. J Adolesc Health. 2016;59(4S):S61–S75.
  • Benyon K, Hill S, Zadurian N, Mallen C. Coping strategies and self-efficacy as predictors of outcome in osteoarthritis: a systematic review. Musculoskeletal Care. 2010;8(4):224–236.
  • Van Denburg AN, Vilardaga JP, Shelby RA, Keefe FJ. Opioid therapy and persistent pain: can cognitive behavioral therapy help? Pain. 2018;159(3):411–415.
  • Hilton L, Hempel S, Ewing BA, et al. Mindfulness meditation for chronic pain: systematic review and meta-analysis. Ann Behav Med. 2017;51(2):199–213.
  • Jacobsen LK, Southwick SM, Kosten TR. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry. 2001;158(8):1184–1190.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.